HCA Healthcare (NYSE:HCA) Downgraded by TheStreet

HCA Healthcare (NYSE:HCA) was downgraded by research analysts at TheStreet from a “b” rating to a “c+” rating in a research report issued on Tuesday, TheStreetRatingsTable reports.

Other equities research analysts also recently issued reports about the company. started coverage on HCA Healthcare in a research report on Thursday, May 13th. They set a “neutral” rating and a $215.00 target price on the stock. Mizuho lifted their price objective on HCA Healthcare from $232.00 to $275.00 and gave the company a “buy” rating in a report on Wednesday. Barclays lifted their price objective on HCA Healthcare from $195.00 to $225.00 and gave the company an “overweight” rating in a report on Friday, April 23rd. They noted that the move was a valuation call. Seaport Res Ptn reiterated a “buy” rating on shares of HCA Healthcare in a research note on Friday, July 9th. Finally, Citigroup lifted their target price on shares of HCA Healthcare from $215.00 to $268.00 and gave the company a “neutral” rating in a research note on Wednesday. Four research analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $231.48.

Shares of NYSE:HCA opened at $249.25 on Tuesday. The firm has a market capitalization of $82.41 billion, a P/E ratio of 17.10, a P/E/G ratio of 1.21 and a beta of 1.63. The company has a 50-day simple moving average of $212.68. HCA Healthcare has a 52-week low of $114.38 and a 52-week high of $254.45. The company has a current ratio of 1.45, a quick ratio of 1.15 and a debt-to-equity ratio of 18.06.

HCA Healthcare (NYSE:HCA) last released its earnings results on Monday, July 19th. The company reported $4.37 earnings per share for the quarter, topping analysts’ consensus estimates of $3.16 by $1.21. HCA Healthcare had a return on equity of 234.29% and a net margin of 8.87%. The business had revenue of $14.44 billion for the quarter, compared to the consensus estimate of $13.61 billion. During the same period last year, the business earned $3.23 earnings per share. The firm’s revenue for the quarter was up 30.4% compared to the same quarter last year. Research analysts predict that HCA Healthcare will post 16.7 EPS for the current fiscal year.

In related news, CMO Jonathan B. Perlin sold 37,305 shares of the company’s stock in a transaction on Friday, April 23rd. The shares were sold at an average price of $200.03, for a total value of $7,462,119.15. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider A Bruce Moore, Jr. sold 12,000 shares of the company’s stock in a transaction on Monday, May 3rd. The stock was sold at an average price of $205.32, for a total transaction of $2,463,840.00. Following the completion of the transaction, the insider now directly owns 102,381 shares of the company’s stock, valued at $21,020,866.92. The disclosure for this sale can be found here. Insiders sold a total of 342,446 shares of company stock valued at $68,773,585 in the last three months. 1.60% of the stock is owned by company insiders.

Several hedge funds have recently modified their holdings of HCA. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in shares of HCA Healthcare by 478.4% in the 4th quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 6,600 shares of the company’s stock valued at $1,085,000 after purchasing an additional 5,459 shares during the period. LPL Financial LLC raised its holdings in shares of HCA Healthcare by 13.6% in the 4th quarter. LPL Financial LLC now owns 40,433 shares of the company’s stock valued at $6,650,000 after purchasing an additional 4,835 shares during the period. Brown Advisory Inc. bought a new stake in shares of HCA Healthcare in the 4th quarter valued at about $269,000. Guggenheim Capital LLC raised its holdings in HCA Healthcare by 1.5% in the 4th quarter. Guggenheim Capital LLC now owns 64,608 shares of the company’s stock valued at $10,625,000 after acquiring an additional 953 shares during the period. Finally, Edge Capital Group LLC raised its holdings in HCA Healthcare by 3.1% in the 4th quarter. Edge Capital Group LLC now owns 13,959 shares of the company’s stock valued at $2,296,000 after acquiring an additional 420 shares during the period. 68.68% of the stock is currently owned by institutional investors.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, operates as a health care services company in the United States. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Recommended Story: What is a price target?

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.